×
About 25,940 results

ALLMedicine™ Hypoglycemia Center

Research & Reviews  7,320 results

Dual sodium-glucose cotransporter (SGLT) 1/2 versus pure SGLT2 inhibitors: two distinct...
https://doi.org/10.1080/14656566.2022.2113385
Expert Opinion on Pharmacotherapy; Koufakis T, Doumas M et. al.

Aug 14th, 2022 - According to their selectivity for sodium-glucose cotransporters (SGLT) 1 and 2, gliflozins could be subdivided into two additional categories: pure SGLT2 inhibitors, which are highly selective for SGLT2, and dual SGLT1/2 inhibitors which, in addi...

The modern pharmacological approach to diabetes: innovative methods of monitoring and i...
https://doi.org/10.1080/17434440.2022.2113387
Expert Review of Medical Devices; Tătaru I, Dragostin OM et. al.

Aug 14th, 2022 - Diabetes mellitus, commonly known as just diabetes, is a group of metabolic disorders characterised by a high blood sugar level over a prolonged period of time. In order to maintain this blood glucose value in normal parameters, a careful monitori...

Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with t...
https://doi.org/10.1016/j.numecd.2022.06.003
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Buzzetti R, Fadini GP et. al.

Aug 13th, 2022 - Data on second generation basal insulin (2BI) in people with type 2 diabetes (T2D) generated by clinical trials still need confirmation in real-world clinical settings. This study aimed at assessing the comparative effectiveness of 2BI [Glargine 3...

Practical Considerations for Use of Insulin/Glucagon-Like Peptide 1 Receptor Agonist Co...
https://doi.org/10.12788/jfp.0394
The Journal of Family Practice; Champlain JM

Aug 13th, 2022 - Over 25% of adults ≥65 years of age have type 2 diabetes (T2D). Individualization of care is important in older adults with T2D, with treatment targets and therapeutic approaches informed by patient-specific medical, psychosocial, functional, and ...

The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregna...
https://doi.org/10.3390/ijerph19159616
International Journal of Environmental Research and Publi... de Bruin R, van Dalen SL et. al.

Aug 13th, 2022 - Beta-blockers are often used during pregnancy to treat cardiovascular diseases. The described neonatal side effects of maternal beta-blocker use are hypoglycemia and bradycardia, but the evidence base for these is yet to be evaluated comprehensive...

see more →

Guidelines  16 results

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation St...
https://doi.org/10.1001/jama.2021.11922
JAMA , Davidson KW et. al.

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroid...
https://doi.org/10.1016/j.ajog.2021.07.023
American Journal of Obstetrics and Gynecology; , Reddy UM et. al.

Aug 8th, 2021 - The administration of antenatal corticosteroids has been widely adopted as the standard of care in the management of pregnancies at risk for preterm delivery before 37 weeks of gestation, with the primary goal of reducing neonatal morbidity. Howev...

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diag...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855268
Journal of Inherited Metabolic Disease; Altassan R, Radenkovic S et. al.

Jul 19th, 2020 - Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CD...

Guideline No. 393-Diabetes in Pregnancy.
https://doi.org/10.1016/j.jogc.2019.03.008
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Berger H, Gagnon R et. al.

Dec 2nd, 2019 - This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. The outcomes evaluated were short and long-term maternal outcomes including pre-eclampsia, Caesarean section, future diabetes and ot...

see more →

Drugs  241 results see all →

Clinicaltrials.gov  1,201 results

Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT04790526

Aug 11th, 2022 - From the last three decades, the diabetes mellitus progress quadrupled.The International Diabetes Federation (IDF) approximate that 1 in 11 adults with age between 20 to 79 years have diabetes mellitus. Almost 90 percent of patients diagnosed with...

isCGM With Education and Feedback for Non-Insulin Dependent Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT05319496

Aug 10th, 2022 - Objective: To evaluate the effectiveness of intermittently scanned continuous glucose monitoring (isCGM) with education and feedback on glycemic control at 12 weeks, in adults with type 2 diabetes and uncontrolled HbA1c (> 7.0%) not on insulin the...

Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)
https://clinicaltrials.gov/ct2/show/NCT05307237

Aug 10th, 2022 - There is strong evidence that poor glycemic control in the hospital is common. Given the known consequences of uncontrolled blood sugars during a hospitalization (e.g., infection, serious neurological and cardiac complications, mortality, longer l...

Cognition in Patients With Hypoglycemia, Without Diabetes
https://clinicaltrials.gov/ct2/show/NCT04430582

Aug 9th, 2022 - This study will test the hypothesis that recurrent hypoglycemia is associated with differences in cognition (thinking), by analyzing results of cognitive testing in individuals with a history of hypoglycemia as compared with those without known hy...

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT04786262

Aug 9th, 2022 - This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

see more →

News  1,577 results

A Brighter Future for Those With Type 1 Diabetes
https://www.medscape.com/viewarticle/977615

Aug 2nd, 2022 - This transcript has been edited for clarity. What an amazing time it is to be living with type 1 diabetes in 2022 and see the evolution of diabetes technology. I say this both personally and professionally. My brother was diagnosed with type 1 in ...

Episodes of visual disturbance
https://www.mdedge.com/migraine-challenge-center/article/256718/migraine/episodes-visual-disturbance

Aug 1st, 2022 - On the basis of the history, examination, and investigations, retinal migraine was diagnosed according to the International Classification of Headache Disorders, third edition (1. 2 migraine with aura; 1.

Neuropathy Drives Hypoglycemia Cluelessness in T1D
https://www.medscape.com/viewarticle/978399

Aug 1st, 2022 - Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed. Key Takeaways In Japanese adults with type 1 diabetes insulin-pump treatment (continuous subcutaneous insulin infusion...

Real-world insights of initiating or switching to insulin degludec/aspart in T2D
https://www.mdedge.com/type-2-diabetes-icymi/article/256649/diabetes/real-world-insights-initiating-or-switching-insulin

Jul 31st, 2022 - Key clinical point: In patients with type 2 diabetes (T2D), initiating or switching to insulin degludec/ aspart (IDegAsp) from other antidiabetic treatments was associated with improved glycemic control, lower basal insulin dose requirement in ins.

The Team Approach to Managing Type 2 Diabetes
https://www.mdedge.com/type-2-diabetes-icymi/article/256290/diabetes/team-approach-managing-type-2-diabetes
Rozalina G. McCoy, MD, MS

Jul 25th, 2022 - Those of us who treat patients with type 2 diabetes (T2D) daily have long recognized a disturbing irony: diabetes is a disease whose management requires consistency in approach and constancy in delivery, but it is most prevalent among those whose.

see more →

Patient Education  21 results see all →